Bitcoin saw a strong rebound, climbing back above the $105,000 level after a weekend sell-off broke the psychological $100,000 threshold. Traders attributed the reversal to a late-night peace agreement between Israel and Iran, which calmed markets and revived risk appetite. Today, U.S. stock indices are also rising toward historical highs.
Risk sentiment was further boosted by comments from two FOMC members, Fed officials Michelle Bowman and Christopher Waller, who expressed support for a rate cut as early as July.
On the regulatory front, the Federal Housing Finance Agency (FHFA) confirmed it is exploring the possibility of including Bitcoin and other digital assets in creditworthiness assessments during the mortgage approval process. This could mark the first step toward broader use of cryptocurrencies in the U.S. credit market.
Despite the recent market panic, spot Bitcoin ETFs saw another $350 million in net inflows on Monday — the tenth consecutive day of gains — helping to offset Sunday’s sell-off.
Meanwhile, Metaplanet Inc. approved a new funding round to purchase approximately $5 billion worth of BTC on behalf of its subsidiary, Metaplanet Treasury Corp., based in Florida.
Texas is set to become the first U.S. state to include Bitcoin on its balance sheet, after Governor Greg Abbott signed SB21, establishing a publicly funded strategic reserve — a move analysts say could inspire similar actions across the country.
All of these developments are contributing to the increasingly aggressive institutional adoption of Bitcoin, supporting its price, which remains above the $100,000 mark.
Daily Summary: U.S. stock indices are climbing following the PPI data
US OPEN: Wall Street Rallies on Soft PPI Data
BREAKING: US PPI comes in weaker than expected. EURUSD gains ground
JP Morgan earnings: Good, but it could have been better
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
